0001493152-24-011216.txt : 20240325
0001493152-24-011216.hdr.sgml : 20240325
20240325213015
ACCESSION NUMBER: 0001493152-24-011216
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240321
FILED AS OF DATE: 20240325
DATE AS OF CHANGE: 20240325
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fuggetta Gianluca
CENTRAL INDEX KEY: 0001958188
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40237
FILM NUMBER: 24780774
MAIL ADDRESS:
STREET 1: C/O GAIN THERAPEUTICS, INC.
STREET 2: 4800 MONTGOMERY LANE, SUITE 220
CITY: BETHESDA
STATE: MD
ZIP: 20814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gain Therapeutics, Inc.
CENTRAL INDEX KEY: 0001819411
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 851726310
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4800 HAMPDEN LANE
STREET 2: SUITE 200
CITY: BETHESDA
STATE: MD
ZIP: 20814
BUSINESS PHONE: (301) 500-1556
MAIL ADDRESS:
STREET 1: 4800 HAMPDEN LANE
STREET 2: SUITE 200
CITY: BETHESDA
STATE: MD
ZIP: 20814
4
1
ownership.xml
X0508
4
2024-03-21
0
0001819411
Gain Therapeutics, Inc.
GANX
0001958188
Fuggetta Gianluca
C/O GAIN THERAPEUTICS, INC.
4800 MONTGOMERY LANE, SUITE 220
BETHESDA
MD
20814
0
1
0
0
See Remark
0
Employee Stock Option (right to buy)
4.37
2024-03-21
4
A
0
50000
0.00
A
2034-03-21
Common Stock
50000
50000
D
The shares underlying the option shall vest 25% on March 21, 2025 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
Principal Accounting and Financial Officer
/s/ Matthias Alder, Attorney-In-Fact
2024-03-25